Join
Live feed
·
PRReleasevia Quantisnow
Dr. Reddy's Laboratories Ltd logo

Dr. Reddy's Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States

ByQuantisnow·Wall Street's wire, on your screen.
RDY· Dr. Reddy's Laboratories Ltd
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RDY (Dr. Reddy's Laboratories Ltd) and more on Quantisnow.